Research perspectives in inherited lymphatic disease

Annals of the New York Academy of Sciences

Volumn 979, Issue , 2002, Pages 39-51

  Ferrell, Robert E ^a  

^a UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Aagenaes' syndrome; FOXC2; Hennekam's syndrome; Lymphedema; Lymphedemadistichiasis; Noonan's syndrome; VEGF C; VEGFR3

Indexed keywords

VASCULOTROPIN C; VASCULOTROPIN RECEPTOR 3;

AAGENAE SYNDROME; ALPHA 1 ANTITRYPSIN DEFICIENCY; CONFERENCE PAPER; GENE MUTATION; GENE TRANSFER; GENETIC ANALYSIS; GENETIC DISORDER; GENETIC IDENTIFICATION; HENNEKAM LYMPHANGIECTASIA LYMPHEDEMA; HUMAN; LYMPHATIC SYSTEM DISEASE; LYMPHEDEMA; LYMPHEDEMA DISTICHIASIS SYNDROME; MILROY DISEASE; NONHUMAN; NOONAN SYNDROME; PTOSIS; TRANSGENE; YELLOW NAIL SYNDROME;

EID: 0036964966     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2002.tb04866.x     Document Type: Conference Paper

References (62)

1. MILROY, W.F. 1892. An undescribed variety of hereditary oedema. N.Y. Med. J. 56: 505-508.
2. NONNE, M. 1891. Vier fälle von elephantiasis congenita heredituria. Virchows Arch. Pathol. Anat. 125: 189-196.
3. FERRELL, R.E., K.M. LEVINSON, J.H. ESMAN, et al. 1998. Hereditary lymphedema: evidence for linkage and genetic heterogeneity. Hum. Mol. Genet. 7: 2073-2078.
4. WITTE, M.H., R. ERICKSON, M. BERNAS, et al. 1998. Phenotypic and genotypic heterogeneity in familial Milroy lymphedema. Lymphology 31: 145-155.
5. EVANS, A.L., G. BRICE, V. SOTIROVA, et al. 1999. Mapping of primary congenital lymphedema to the 5q35.3 region. Am. J. Hum. Genet. 64: 547-555.
6. KARKKAINEN, M.J., R.E. FERRELL, E.C. LAWRENCE, et al. 2000. Missense mutations interfere with VEGFR-3 signalling in primary lymphedema. Nature Genet. 25: 153-159.
7. IRRTHUM, A., M.J. KARKKAINEN, K. DIVRIENDT, et al. 2000. Congenital hereditary lymphedema caused by a mutation that inactivates VEGFR3 tyrosine kinase. Am. J. Hum. Genet. 67: 295-301.
8. VAN DER GEER, P., T. HUNTER & R.A. LINDBERG. 1994. Receptor protein-tyrosine kinases and their signal transduction pathways. Annu. Rev. Cell Biol. 10: 251-337.
9. KLAGSBRUN, M. & P.A. D'AMORE. 1996. Vascular endothelial growth factor and its receptor. Cytokine Growth Factor Rev. 7: 259-270.
10. JOUKOV, V., K. PAJUSOLA, A. KAIPAINEN, et al. 1996. A novel vascular endothelial growth factor, VEGFC, is a ligand for the Flt4 (VEGFR3) and KDR (VEGFR2) receptor tyrosine kinases. EMBO J. 15: 290-298.
11. ACHEN, M.G., M. JELTSCH, E. KUKK, et al. 1998. Vascular endothelial growth factor D (VEGFD) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4). Proc. Natl. Acad. Sci. USA 95: 548-553.
12. DUMONT, D.J., L. JUSSILA, J. TAIPALE, et al. 1998. Cardiovascular failure in mouse embryos deficient in VEGF receptor-3. Science 282: 946-949.
13. KAIPAINEN, A., J. KORHONEN, T. MUSTONEN, et al. 1995. Expression of the fms-like tyrosine kinase-4 gene becomes restricted to lymphatic endothelium during development. Proc. Natl. Acad. Sci. USA 92: 3566-3570.
14. KUKK, E., A. LYMBOUSSAKI, S. TAIRA, et al. 1996. VEGF-C receptor binding and pattern of expression with VEGFR-3 suggests a role in lymphatic vascular development. Development 122: 3829-3837.
15. MAKINEN, T., L. JUSSILA, T. VEIKKOLA, et al. 2001. Inhibition of lymphangiogenesis with resulting lymphedema in transgenic mice expressing soluble VEGF-receptor-3. Nature Med. 7: 199-205.
16. PATTERSON, D.F., W. MEDWAY, H. LUGINBUHL & S. CHACKO. 1967. Congenital hereditary lymphedema in the dog. Clinical and genetic studies. J. Med. Genet. 4: 145-152.
17. LUGINBUHL, H., S.K. CHACKO, D.F. PATTERSON & W. MEDWAY. 1967. Congenital hereditary lymphedema in the dog. Pathological studies. J. Med. Genet. 4: 153-165.
18. VAN DER PUTTE, S.C. 1978. Congenital hereditary lymphedema in the pig. Lymphology 11: 1-9.
19. MORRIS, B., D.C. BLOOD, W.R. SIDMAN, et al. 1954. Congenital lymphatic oedema in Ayrshire calves. Austr. J. Exp. Biol. 32: 265-274.
20. LYON, M.F. & P.H. GLENISTER. 1984. Chylous ascites (Chy). Mouse News Lett. 71: 26.
21. LYON, M.F. & P.H. GLENISTER. 1986. Gene order of chy-vt-re on mouse chromosome 11. Mouse News Lett. 74: 96.
22. KARKKAINEN, M.J., A. SAARISTO, L. JUSSILA, et al. 2001. A model for gene therapy of human hereditary lymphedema. Proc. Natl. Acad. Sci. USA 98: 12677-12682.
23. VEIKKOLA, T., L. JUSSILA, T. MAKINEN, et al. 2001. Signaling via vascular endothelial growth factor receptor-3 is sufficient for lymphangiogenesis in transgenic mice. EMBO J. 20: 1223-1231.
24. BARBER, J.C., I.K. TEMPLE, P.L. CAMPBELL, et al. 1996. Unbalanced translocation in a mother and her son in one of two 5;10 translocation families. Am. J. Med. Genet. 62: 84-90.
25. GROEN, S.E., K.G. DREWES, E.G. DE BOER, et al. 1998. Repeated unbalanced offspring due to a familial translocation involving chromosomes 5 and 6. Am. J. Med. Genet. 80: 448-453.
26. DI FIORE, P.P. & P. DE CAMILLI. 2001. Endocytosis and signaling, an inseparable partnership. Cell 106: 1-4.
27. SMELTZER, D.M., G.B. STICKLER & A. SCHIRGER. 1985. Primary lymphedema in children and adolescents: A follow-up study and review. Pediatrics 76: 206-218.
28. SCHIRGER, A., E.G. HARRISON, JR. & J.M. JAMES. 1962. Idiopathic lymphedema: Review of 131 cases. J. Am. Med. Assoc. 182: 14-22.
29. KINMONTH, J.B., G.W. TAYLOR & G.D. TRACY. 1957. Primary lymphedema: Clinical and lymphangiographic studies of a series of 107 patients in which the lower limbs were affected. Br. J. Surg. 45: 1-10.
30. FEINS, N.R., R. RUBIN, T. CRAIS & J.F. O'CONNOR. 1977. Surgical management of thirty-nine children with lymphedema. J. Pediatr. Surg. 12: 471-476.
31. DALE, R.F. 1987. Primary lymphoedema when found with distichiasis is of the type defined as bilateral hyperplasia by lymphography. J. Med. Genet. 24: 170-171.
32. FALLS, H.F. & E.D. KERTESZ. 1964. A new syndrome combining pterygium colli with developmental abnormalities of the eyelids and lymphatics of the lower limbs. Trans. Am. Ophthalmic Soc. 62: 248-275.
33. CHYNN, K.Y. 1967. Congenital spinal extradural cyst in two siblings. Am. J. Roentgen 101: 204-215.
34. PAP, Z., T. BIRO, L. SZABO & Z. PAPP. 1980. Syndrome of lymphoedema and distichiasis. Hum. Genet. 53: 309-310.
35. CORBETT, C.R.R., R.F. DALE, D.J. COLTART & J.B. KINMOUTH. 1982. Congenital heart disease in patients with primary lymphedemas. Lymphology 15: 85-90.
36. GOLDSTEIN, S., Q.H. QAZI, J. FITZGERALD, et al. 1985. Distichiasis, congenital heart defects and mixed peripheral vascular anomalies. Am. J. Med. Genet. 20: 283-294.
37. BARTLEY, G.B. & I.T. JACKSON. 1989. Distichiasis and cleft palate. Plastic Reconstr. Surg. 84: 129-132.
38. MANGION, J., N. RAHMAN, S. MONSOUR, et al. 1999. A gene for lymphedema-distichiasis maps to 16q24.3. Am. J. Hum. Genet. 65: 427-432.
39. BELL, R., G. BRICE, A.H. CHILD, et al. 2000. Reduction of the genetic interval of lymphoedema-distichiasis to below 2-Mb. J. Med. Genet. 37: 725-726.
40. FANG, J., S.L. DAGENAIS, R.P. ERICKSON, et al. 2000. Mutations in FOXC2, a forkhead family transcription factor, are responsible for hereditary lymphedema-distichiasis syndrome. Am. J. Hum. Genet. 67: 1382-1388.
41. FINEGOLD, D.N., M.A. KIMAK, E.C. LAWRENCE, et al. 2001. Truncating mutation in FOXC2 cause multiple lymphedema syndromes. Hum. Mol. Genet. 10: 1185-1189.
42. ERICKSON, R.P., S.L. DAGENAIS, M.S. CAULDER, et al. 2001. Clinical heterogeneity in lymphedema-distichiasis with FOXC2 truncating mutations. J. Med. Genet. 38: 761-766.
43. BELL, R., G. BRICE, A.H. CHILD, et al. 2001. Analysis of lymphedema-distichiasis families for FOXC2 mutations reveals small insertions and deletions throughout the gene. Hum. Genet. 108: 546-551.
44. WEIGEL, D., G. JURGENS, F. KUTTNER, et al. 1989. The homeotic gene fork head encodes a nuclear protein and is expressed in the terminal regions of the Drosophila embryo. Cell 57: 645-658.
45. WINNIER, G.E., L. HARGETT & B.L.M. HOGAN. 1997. The winged helix transcription factor MFH1 is required for proliferation and patterning of paraxial mesoderm in the mouse embryo. Genes Development 11: 926-940.
46. IIDA, K., H. KOSEKI, H. KAKINUMA, et al. 1997. Essential role of the winged helix transcription factor MFH-1 in aortic arch patterning and skeletogenesis. Development 124: 4627-4638.
47. SMITH, R.S., A. ZABALETA, T. KUME, et al. 2000. Haploinsufficiency of the transcription factors FOXC1 and FOXC2 results in aberrant ocular development. Hum. Mol. Genet. 9: 1021-1032.
48. CEDERBERG, A., L.M. GRONNING, B. AHREN, et al. 2001. FOXC2 is a winged helix gene that counteracts obesity, hypertriglyceridemia, and diet-induced insulin resistance. Cell 106: 563-573.
49. WITT, D.R., H.E. HOYME, J. ZONANA, et al. 1987. Lymphedema in Noonan syndrome: Clues to pathogenesis and prenatal diagnosis and review of the literature. Am. J. Med. Genet. 27: 841-856.
50. JAMIESON, C.R., I. VAN DER BURGT, A.F. BRADY, et al. 1994. Mapping a gene for Noonan syndrome to the long arm of chromosome 12. Nature Genet. 8: 357-360.
51. BRADY, A.F., C.R. JAMIESON, I. VAN DER BURGT, et al. 1997. Further delineation of the critical region for Noonan syndrome on the long arm of chromosome 12. Eur. J. Hum. Genet. 5: 336-337.
52. LEGIUS, E., E. SCHOLLEN, G. MATTHIJS & J.P. FRYNS. 1998. Fine mapping of Noonan/cardio-facial cutaneous syndrome in a larger family. Eur. J. Hum. Genet. 6: 32-37.
53. TARTAGLIA, M., E.L. MEHLER, R. GOLDBERG, et al. 2001. Mutations in PTPN11, encoding the protein tyrosine phosphatase SPH-2, cause Noonan syndrome. Nature Genet. 29: 465-468.
54. FENG, G.S. 1999. SPH-2 tyrosine phosphatase: signaling one cell or many. Exp. Cell Res. 253: 47-54.
55. STEIN-GERLACH, M., C. WALLASCH & A. ULLRICH. 1998. SPH-2 SH-2 containing protein tyrosine phosphatase-2. Int. J. Biochem. Cell Biol. 30: 559-566.
56. TAMIR, I., J.M. DALPORTO & J.C. CAMBIER. 2000. Cytoplasmic protein tyrosine phosphatase SHP-1 and SHR2: regulators of B cell signal transduction. Curr. Opin. Immunol. 12: 307-315.
57. FERRELL, R.E. & D.N. FINEGOLD. 2002. Personal communication.
58. AAGENAES, O., C.B. VAN DER HAGEN & S. REFSUM. 1968. Hereditary recurrent intrahepatic cholestasis from birth. Arch. Dis. Child 43: 646-657.
59. AAGENAES, O., H. SIGSTAD & R. BJORN-HANSEN. 1970. Lymphedema in hereditary recurrent cholestasis from birth. Arch. Dis. Child 45: 690-695.
60. AAGENAES, O. 1998. Hereditary cholestasis with lymphedema. Scand. J. Gastroenterol. 33: 335-345.
61. BULL, L.N., E. ROCHE, E.J. SONG, et al. 2000. Mapping of the locus for cholestasis-lymphedema syndrome (Aagenaes syndrome) to a 6.6 cM interval on chromosome 15q. Am. J. Hum. Genet. 67: 994-999.
62. HENNEKAM, R.C.M., R.A. GEERDINK, B.C.J. HAMEL, et al. 1989. Autosomal recessive intestinal lymphangiectasia and lymphedema, with facial anomalies and mental retardation. Am. J. Med. Genet. 34: 593-600.